At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 61 enrolled
Drug / intervention
DFD-04 Ointment +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-center, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of DFD-04 (Itraconazole) Ointment, 5% in Patients With Inflammatory Lesions of Rosacea Over 12 Weeks
In Brief
A Phase 2 clinical trial evaluating DFD-04 Ointment and Placebo Ointment for Rosacea. Completed, enrolled 61 participants across 8 sites.
Detailed Summary
The purpose of this exploratory study is to assess the efficacy, safety and tolerability of DFD-04 Ointment for topical treatment of rosacea over 12 weeks of treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRosacea
CountriesGermany
Collaborators--
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJul 2016
First PostedJul 2016
Primary CompletionJan 2017
Study CompletionNov 2017
TodayJul 2026
First PostedJul 11, 2016
Enrollment StartJul 1, 2016
Primary CompletionJan 1, 2017
Study CompletionNov 1, 2017
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 10.0 years ago
Interventions
DFD-04 Ointmentdrug
Placebo Ointmentother